
Mayne
MYX.AXMayne Pharma Group Limited Price (MYX.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
79,620,000
(2.0011)%Description
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's... Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $3.74-7.46
- Market Cap 586.59M
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Drug Manufacturers - General
- ceo: Mr. Shawn Patrick O'Brien B.Sc
- IPO Date: June, 29, 2007
- Country: AU
- Currency: AUD
- Headquaters: Salisbury South, SA
- Employees: 850
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
